Company Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion.
It markets its products primarily with a direct sales force, as well as through distributors.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.
| Country | United States |
| IPO Date | Oct 17, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 344 |
| CEO | Laura A. Francis MBA |
Contact Details
Address: 471 El Camino Real Santa Clara, California United States | |
| Website | https://si-bone.com |
Stock Details
| Ticker Symbol | SIBN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001459839 |
| CUSIP Number | 825704109 |
| ISIN Number | US8257041090 |
| Employer ID | 26-2216351 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Laura A. Francis MBA | Chief Executive Officer & Director |
| Anshul Maheshwari | Chief Financial Officer |
| Dr. Scott A. Yerby | Senior Vice President of Engineering & Chief Technology Officer |
| Aimee Einstein | Vice President of People & Culture |
| Anthony J. Recupero | President of Commercial Operations |
| Dr. Daniel Joseph Cher | Senior Vice President of Clinical & Regulatory Affairs |
| Dr. W. Carlton Reckling | Chief Medical Officer & Vice President of Medical Affairs |
| Michael A. Pisetsky J.D. | Chief Business & Legal Affairs Officer, Secretary and General Counsel |
| Nikolas F. Kerr | Senior Vice President of Product, Strategy & Business Development |
| Saqib Iqbal | Director of FP&A and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 4 | Filing |
| Jan 06, 2025 | 4 | Filing |
| Nov 20, 2024 | 4 | Filing |
| Nov 20, 2024 | 4 | Filing |
| Nov 20, 2024 | 4 | Filing |
| Nov 20, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 12, 2024 | 10-Q | Quarterly Report |